IQVIA Holdings (IQV) Expands Its Veeva Tie Up, Is It Still 6% Undervalued?

Simply Wall St.10-23

IQVIA Holdings (IQV) is back in focus after selecting Veeva CTMS, eTMF, Study Startup, and Site Connect as standard tools across its clinical development work, extending an earlier collaboration on ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2677960746?lang=en_US&edition=fundamental","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/137473239-card/1788946130635","is_english":true,"pubTime":"2026-10-23 00:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2677960746","market":"hk","top_or_hot":-1,"title":"IQVIA Holdings (IQV) Expands Its Veeva Tie Up, Is It Still 6% Undervalued?","media":"Simply Wall St.","content":"<div>\n<p>IQVIA Holdings (IQV) is back in focus after selecting Veeva CTMS, eTMF, Study Startup, and Site Connect as standard tools across its clinical development work, extending an earlier collaboration on ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-iqv/iqvia-holdings/news/iqvia-holdings-iqv-expands-its-veeva-tie-up-is-it-still-6-un\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IQVIA Holdings (IQV) Expands Its Veeva Tie Up, Is It Still 6% Undervalued?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIQVIA Holdings (IQV) Expands Its Veeva Tie Up, Is It Still 6% Undervalued?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-10-23 00:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-iqv/iqvia-holdings/news/iqvia-holdings-iqv-expands-its-veeva-tie-up-is-it-still-6-un><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>IQVIA Holdings (IQV) is back in focus after selecting Veeva CTMS, eTMF, Study Startup, and Site Connect as standard tools across its clinical development work, extending an earlier collaboration on ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-iqv/iqvia-holdings/news/iqvia-holdings-iqv-expands-its-veeva-tie-up-is-it-still-6-un\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0289739699.SGD","symbol_name":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-iqv/iqvia-holdings/news/iqvia-holdings-iqv-expands-its-veeva-tie-up-is-it-still-6-un","article_id":"2677960746","we_media_id":null,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/137473239-card/1788946130635"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-iqv/iqvia-holdings/news/iqvia-holdings-iqv-expands-its-veeva-tie-up-is-it-still-6-un","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2677960746","pubTimestamp":1792687206,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"IQVIA Holdings (IQV) is back in focus after selecting Veeva CTMS, eTMF, Study Startup, and Site Connect as standard tools across its clinical development work, extending an earlier collaboration on electronic data capture.\nThat technology update lands at a time when IQVIA Holdings has already been regaining momentum, with a 1 day share price return of 3.28% and a 90 day share price return of 33.43% feeding into a 1 year total shareholder return of 26.98%. This suggests sentiment has been...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","BK4504":"桥水持仓","BK4167":"医疗保健技术","LGHT":"LANGAR GLOBAL HEALTHTECH ETF","LU1989764664.SGD":"CPR Invest - Global Disruptive Opportunities A2 Acc SGD-H","LU0528227936.USD":"富达环球人口趋势基金A-ACC","BK4588":"碎股","BK4530":"医药外包概念","HEAL":"Global X HealthTech ETF","LU0198837287.USD":"UBS (LUX) EQUITY SICAV - USA GROWTH \"P\" (USD) ACC","BK4528":"SaaS概念","LU1989764748.USD":"东方汇理环球颠覆性机遇A2 Acc","EKG":"First Trust Nasdaq Lux Digital Health Solutions ETF","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","BK4534":"瑞士信贷持仓","LU0130103400.USD":"Natixis Harris Associates Global Equity RA USD","LU0477156953.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"RE\" (USD) ACC","LU1791710582.SGD":"Fidelity Global Demographics A-ACC-SGD (SGD/USD hedged)","VEEV":"Veeva Systems Inc.","LU0477156797.USD":"HARRIS ASSOCIATES GLOBAL EQUITY \"RE\" (USD) ACC","LU1201861165.SGD":"Natixis Harris Associates Global Equity PA SGD","LU1791710400.SGD":"Fidelity Global Demographics A-ACC-SGD","GB00B4QBRK32.GBP":"FUNDSMITH EQUITY \"R\" (GBP) INC","LU0648000940.SGD":"Natixis Harris Associates Global Equity RA SGD","LU1201861249.SGD":"Natixis Harris Associates US Equity PA SGD-H","LU0130517989.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"R\" INC","BK4121":"生命科学工具和服务","LU0006306889.USD":"SCHRODER ISF US LARGE CAP \"A\" (USD) INC AV","LU0130102774.USD":"Natixis Harris Associates US Equity RA USD","LU0882574055.USD":"富达全球健康医疗A ACC","LU0980610538.SGD":"Natixis Harris Associates US Equity RA SGD-H","GB00B4LPDJ14.GBP":"FUNDSMITH EQUITY \"R\" (GBP) ACC","LU0106261372.USD":"SCHRODER ISF US LARGE CAP \"A\" ACC","LU2404859741.USD":"FUNDSMITH EQUITY FUND \"R\" (USD) INC","LU1261432733.SGD":"Fidelity World A-ACC-SGD","BK4585":"ETF&股票定投概念","LU0648001328.SGD":"Natixis Harris Associates US Equity RA SGD","LU2404859667.USD":"FUNDSMITH EQUITY FUND \"R\" (USD) ACC","LU0130518102.USD":"HARRIS ASSOCIATES GLOBAL EQUITY \"R\" INC","LU0690374961.EUR":"FUNDSMITH EQUITY \"R\" (EUR) INC","LU0058720904.USD":"联博国际健康护理基金A","LU0690374615.EUR":"FUNDSMITH EQUITY \"R\" (EUR) ACC","IQV":"艾昆纬","BK4613":"AI应用软件","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD"},"translate_title":"IQVIA Holdings (IQV) 扩大与 Veeva 的合作，其估值仍然被低估 6%？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IQV":1.5,"LGHT":0.6,"VEEV":1.5,"HEAL":0.6,"EKG":0.6},"content_text":"IQVIA Holdings (IQV) is back in focus after selecting Veeva CTMS, eTMF, Study Startup, and Site Connect as standard tools across its clinical development work, extending an earlier collaboration on electronic data capture. That technology update lands at a time when IQVIA Holdings has already been regaining momentum, with a 1 day share price return of 3.28% and a 90 day share price return of 33.43% feeding into a 1 year total shareholder return of 26.98%. This suggests sentiment has been improving ahead of the upcoming earnings report. Scan how IQVIA Holdings fits alongside other clinically focused data and healthcare technology players by reviewing our hand picked 37 healthcare AI stocks. After a 33% move in 90 days, the real tension around IQVIA Holdings now sits in the gap between its recent price and the range of fair value estimates. How wide is that gap really? AdvertisementMost Popular Narrative: 6% Undervalued On the most followed view of IQVIA Holdings, a fair value of about $295 sits modestly above the recent $276.63 close. This puts the focus squarely on whether the existing growth engine can justify that gap.  The main thing that has to go right is that IQVIA Holdings continues to convert strong R&DS bookings, a large backlog and growing Commercial Solutions activity, including with emerging biopharma customers, into sustained revenue and earnings growth despite margin and debt headwinds.  See why 19 investors see IQVIA Holdings as 6% undervalued. Result: Fair Value of $295.05 (UNDERVALUED) Still, heavy leverage of around 3.6x adjusted EBITDA and ongoing pricing pressure across CRO contracts could quickly challenge the 6% undervalued narrative for IQVIA Holdings. Find out about the key risks to this IQVIA Holdings narrative. Next Steps Mixed on IQVIA Holdings after all of this. If you want to move quickly and rely on your own judgment, start by weighing its 3 key rewards and 2 important warning signs. Looking for more investment ideas beyond IQVIA Holdings? If IQVIA Holdings has your attention, do not stop here. Cast a wider net and use data driven tools to pressure test your next move.  Target potential mispricings by scanning a curated 33 high quality undervalued stocks that filters for quality fundamentals at what may be attractive entry points. Prioritise staying power by reviewing a list of solid balance sheet and fundamentals (25 results) that focuses on companies with stronger financial footing and cleaner balance sheets. Get ahead of the crowd by checking a 21 high quality undiscovered gems that highlights lesser known businesses with strong underlying metrics before they hit every watchlist.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2677960746","isCrawlerRequest":true}